Keywords: Psychiatric Disorders, Brain, Spectroscopy, Metabolism, Alcohol Use Disorder (AUD)
Motivation: Oral consumption of the ketone-monoester (R)−3-hydroxybutyl-(R)−3-hydroxybutyrate (HBHB) raises the plasma ketone-body β-hydroxybutyrate (BHB), providing a means to study ketone body metabolism. HBHB Hydrolysis however produces BHB and 1,3-butanediol, which share prominent spectral signatures complicating metabolite quantification.
Goal(s): Investigate feasibility and robustly detection of BHB. Subsequently, investigate brain ketone-body metabolism in alcohol use disorder (AUD).
Approach: HBHB was administered orally, and brain metabolism was monitored over 90 minutes using MRS with 1,3-butanediol included as a reference spectrum.
Results: Combined BHB and the co-edited 1,3-butanediol were robustly detected, though separate quantification of BHB and 1,3-butanediol was challenging due to low concentrations.
Impact: Accurate BHB quantification is critical to evaluate BHB transport into the brain post-keto-ester consumption. A modified J-difference editing strategy is expected to mitigate shortcomings to investigate BHB transport to assess disease severity and gain insights related to craving in AUD.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords